Skip to main content
SpringerLink
Log in

Prevention of the acute graft-versus-host disease (GVHD) in rats by the immunomodulating drug leflunomide

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Summary

The grafting of immunocompetent allogeneic cells into MHC-discordant, genetically nonresponsive F1 hybrids of inbred rat strains consistently leads to an acute, lethal graft-versus-host disease (GVHD). The novel immunomodulating drug leflunomide, which has been shown to be efficacious in animal models of autoimmunity and adverse transplantation reactions, was studied in a rat model of GVHD. It was found that this drug not only was a powerful agent to prevent this otherwise terminal disorder, but was also proficient when used as a therapy of an established GVHD. Since leflunomide has been shown to be efficacious and safe in patients with chronic rheumatoid arthritis, it would also be reasonable to investigate this drug in clinical trials for bone marrow transplantation and GVHD in human beings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bartlett RR, Anagnostopulos H, Zielinski T, Mattar T, Schleyerbach R (1993) Effects of leflunomide on immune responses and models of inflammation. Springer Semin Immunopathol 14:381–394

    PubMed  Google Scholar 

  2. Bartlett RR, Dimitrijevic M, Mattar T, Zielinski T, German T, Rüde E, Thoenes GH et al. (1991) Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of auto-immune disorders and reactions leading to transplantation rejection. Agents Actions 32:11–21

    Google Scholar 

  3. Bartlett RR, Campion G, Musikic P, Schleyerbach R, Zielinski T, Schorlemmer H-U (1994) Lefunomide: a novel immunomodulating drug. In: Lewis AJ, Furst DE (eds) Nonsteroidal anti-inflammatory drugs. Mechanisms and clinical uses, 2nd edn. Marcel Dekker, New York, pp 349–366

    Google Scholar 

  4. Küchle CCA, Thoenes GH, Langer KH, Schorlemmer HU, Bartlett RR, Schleyerbach R (1991) Prevention of kidney and skin graft rejection in rats by leflunomide, a new immunomodulating agent. Transplant Proc 23:1083–1086

    PubMed  Google Scholar 

  5. Murase N, Demetris AJ, Woo J, Tanabe M, Furuya T, Todo S, Starzl TE (1993) Graft-versus-host disease after Brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK 506. Transplantation 55:1–7

    PubMed  Google Scholar 

  6. Renkonen R, Häyry P (1984) Bone marrow transplantation in the rat. I. Histologic correlation and quantification of cellular infiltrates in acute graft-versus-host disease. Am J Pathol 117:462–470

    PubMed  Google Scholar 

  7. Schorlemmer HU, Seiler FR, Bartlett RR (1993) Prolongation of allogeneic transplanted skin grafts and induction of tolerance by leflunomide, a new immunosuppressive isoxazol derivative. Transplant Proc 25:763–767

    PubMed  Google Scholar 

  8. Shaffer D, Muanza T, Blakely ML, Simpson MA, Monaco AP (1993) Prevention of graft-versus-host-disease by RS-61443 in two different rodent models. Transplantation 55:221–223

    PubMed  Google Scholar 

  9. Thoenes GH, Sitter T, Langer KH, Bartlett RR, Schleyerbach R (1989) Leflunomide (HWA 486) inhibits experimental autoimmune tubulointerstitial nephritis in rats. Int J Immunopharmacol 11:921–929

    PubMed  Google Scholar 

  10. Ulrichs K, Kaitschick J, Bartlett RR, Müller-Ruchholtz W (1992) Suppression of natural xenophile antibodies with the novel immunomodulating drug leflunomide. Transplant Proc 24:718–719

    PubMed  Google Scholar 

  11. Williams JW, Xiao F, Foster FF, Chong A, Sharma S, Bartlett RR, Sankary HN (1993) Immunosuppressive effects of leflunomide in a cardiac allograft model. Transplant Proc 2517:745–746

    Google Scholar 

  12. Xiao F, Chong A, Foster P, Shankary H, McChesney L, Williams JM, Frieders D, Williams JW (1993) Leflunomide on rejection in hamster to rat cardiac xenografts. In: Program and Abstracts from Second International Congress on Xenotransplantation, Cambridge, England, September 26–29, 1993. Abstract no. 131

  13. Zielinski T, Müller H-J, Bartlett RR (1993) Effects of leflunomide (HWA 486) on expression of lymphocyte activation markers. Agents Actions 38:C80-C82

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik, Klinikum Innenstadt der Universität München, Ziemssenstrasse 1, D-80336, Munich, Germany

    C. Mrowka & G. H. Thoenes

  2. Department of Pathology, Hoechst AG, Frankfurt, Germany

    K. H. Langer

  3. Department of Immunopharmacology, Hoechst AG, Werk Kalle-Albert, D-65174, Wiesbaden, Germany

    R. R. Bartlett

Authors
  1. C. Mrowka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. H. Thoenes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. H. Langer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. R. Bartlett
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This work was supported by the Wilhelm Sander-Stiftung Neuburg a. d. Donau, Number 90.059.1

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mrowka, C., Thoenes, G.H., Langer, K.H. et al. Prevention of the acute graft-versus-host disease (GVHD) in rats by the immunomodulating drug leflunomide. Ann Hematol 68, 195–199 (1994). https://doi.org/10.1007/BF01834366

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01834366

Key words

Search

Navigation